Bleichroeder LP Reports New 9.99% Stake in Envoy Medical, Inc. (COCH)

On May 14, 2026, Bleichroeder LP, along with Bleichroeder Holdings LLC and Andrew Gundlach, filed a Schedule 13G disclosing a new 9.99% ownership stake in Envoy Medical, Inc. (COCH). The reporting persons beneficially own 7,839,000 shares of Class A Common Stock, which includes 6,250,000 outstanding shares and 1,589,000 shares issuable upon the exercise of warrants. Notably, the total shares reported are capped at 9.99% due to a Beneficial Ownership Limitation in the warrant agreement. Without this limitation, Bleichroeder would be deemed to beneficially own 16,250,000 shares (including 10,000,000 shares from warrants), representing approximately 18.7% of the issuer's outstanding Common Stock. The filing indicates that the securities were acquired in the ordinary course of business and not for the purpose of influencing control over the issuer. Andrew Gundlach serves as the President and CEO for both the LP and the Holdings LLC entities. This position represents a significant new institutional holding for the medical technology company.